The beneficial effect of physical activity on cognitive function in community-dwelling older persons with locomotive syndrome.
Cognitive function
Locomotive syndrome
Older person
Physical activity
Journal
PeerJ
ISSN: 2167-8359
Titre abrégé: PeerJ
Pays: United States
ID NLM: 101603425
Informations de publication
Date de publication:
2021
2021
Historique:
received:
04
12
2020
accepted:
21
09
2021
entrez:
1
11
2021
pubmed:
2
11
2021
medline:
2
11
2021
Statut:
epublish
Résumé
Cognitive decline is closely related to motor decline. Locomotive syndrome (LS) is defined as a state associated with a high risk of requiring support because of locomotive organ disorders, and can be evaluated using a questionnaire. This study aimed to clarify the effectiveness of daily goal-targeted exercise on cognitive function in two different populations classified by scores on the Locomo 25 questionnaire. Seventy community-dwelling older people who participated in a 13-week health class were divided into two populations based on Locomo 25 scores: <7 (non-LS) and ≥7 (LS). Participants were presented with a daily target steps and worked towards that goal. Cognitive function was evaluated using the Japanese version of Addenbrooke's Cognitive Examination-Revised (ACE-R). Average daily physical activity (exercise [Ex]) for 13 weeks was measured using a portable activity meter. Depression status was assessed using the Geriatric Depression Scale (GDS-15). No significant differences were observed in age, years of education, body mass index, smooth muscle mass index, GDS-15 scores, or ACE-R scores between the non-LS and LS populations. Multiple logistic regression analysis showed that Ex (odds ratio = 5.01, These results suggest that Ex ≥ 2.29 METs · h/day is important for improving cognitive function in LS populations.
Sections du résumé
BACKGROUND
BACKGROUND
Cognitive decline is closely related to motor decline. Locomotive syndrome (LS) is defined as a state associated with a high risk of requiring support because of locomotive organ disorders, and can be evaluated using a questionnaire. This study aimed to clarify the effectiveness of daily goal-targeted exercise on cognitive function in two different populations classified by scores on the Locomo 25 questionnaire.
METHODS
METHODS
Seventy community-dwelling older people who participated in a 13-week health class were divided into two populations based on Locomo 25 scores: <7 (non-LS) and ≥7 (LS). Participants were presented with a daily target steps and worked towards that goal. Cognitive function was evaluated using the Japanese version of Addenbrooke's Cognitive Examination-Revised (ACE-R). Average daily physical activity (exercise [Ex]) for 13 weeks was measured using a portable activity meter. Depression status was assessed using the Geriatric Depression Scale (GDS-15).
RESULTS
RESULTS
No significant differences were observed in age, years of education, body mass index, smooth muscle mass index, GDS-15 scores, or ACE-R scores between the non-LS and LS populations. Multiple logistic regression analysis showed that Ex (odds ratio = 5.01,
CONCLUSIONS
CONCLUSIONS
These results suggest that Ex ≥ 2.29 METs · h/day is important for improving cognitive function in LS populations.
Identifiants
pubmed: 34721979
doi: 10.7717/peerj.12292
pii: 12292
pmc: PMC8522643
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e12292Informations de copyright
© 2021 Nakamura et al.
Déclaration de conflit d'intérêts
The authors declare that they have no competing interests.
Références
Curr Alzheimer Res. 2011 Aug;8(5):510-9
pubmed: 21605048
BMC Geriatr. 2016 Sep 27;16(1):166
pubmed: 27677265
Lancet Psychiatry. 2018 Sep;5(9):739-746
pubmed: 30099000
J Gerontol A Biol Sci Med Sci. 2017 May 1;72(5):716-723
pubmed: 27664990
JAMA Intern Med. 2017 Aug 1;177(8):1146-1153
pubmed: 28586818
Environ Health Prev Med. 2006 Jul;11(4):177-83
pubmed: 21432377
Clin Interv Aging. 2018 Apr 30;13:819-827
pubmed: 29750024
Neurology. 2000 Dec 12;55(11):1613-20
pubmed: 11113213
Pain. 2017 Mar;158(3):383-390
pubmed: 28187102
J Geriatr Phys Ther. 2015 Oct-Dec;38(4):202-7
pubmed: 25695472
Nat Rev Neurol. 2011 May 03;7(6):323-31
pubmed: 21537355
Br J Clin Pharmacol. 2013 Mar;75(3):738-55
pubmed: 23384081
Clin Interv Aging. 2017 Sep 12;12:1451-1457
pubmed: 28979107
JAMA Netw Open. 2020 Sep 1;3(9):e2013573
pubmed: 32955572
J Orthop Sci. 2008 Jan;13(1):1-2
pubmed: 18274847
J Orthop Sci. 2012 Mar;17(2):163-72
pubmed: 22222445
Sci Rep. 2021 Jun 15;11(1):12591
pubmed: 34131252
Curr Gerontol Geriatr Res. 2017;2017:4104802
pubmed: 28479917
J Bone Miner Metab. 2009;27(5):620-8
pubmed: 19568689
Int J Behav Nutr Phys Act. 2010 May 11;7:39
pubmed: 20459783
Am J Epidemiol. 2002 Jun 15;155(12):1081-7
pubmed: 12048221
J Am Geriatr Soc. 2017 Apr;65(4):792-799
pubmed: 27869301
Int J Geriatr Psychiatry. 2006 Nov;21(11):1078-85
pubmed: 16977673
Neurology. 2009 Nov 10;73(19):1567-70
pubmed: 19901248
JAMA. 2003 May 14;289(18):2379-86
pubmed: 12746361
PeerJ. 2020 Apr 14;8:e9026
pubmed: 32328357
Neurology. 2014 Aug 19;83(8):718-26
pubmed: 25031288
BMC Geriatr. 2020 Aug 26;20(1):307
pubmed: 32847545
Lancet. 2020 Aug 8;396(10248):413-446
pubmed: 32738937
J Phys Ther Sci. 2018 Jan;30(1):145-149
pubmed: 29410586
J Bone Miner Metab. 2019 Nov;37(6):1058-1066
pubmed: 31222550
J Am Geriatr Soc. 2012 Mar;60(3):505-10
pubmed: 22288578
Ann Intern Med. 2010 Aug 3;153(3):182-93
pubmed: 20547887
Psychiatry Res. 2011 Jan 30;185(1-2):211-4
pubmed: 20537725
Mod Rheumatol. 2014 Mar;24(2):250-7
pubmed: 24593200
Arch Intern Med. 2001 Oct 22;161(19):2309-16
pubmed: 11606146
Geriatr Gerontol Int. 2017 Jan;17(1):54-60
pubmed: 26792269
Neurology. 2019 Feb 19;92(8):e811-e822
pubmed: 30651386
J Gerontol A Biol Sci Med Sci. 2015 Apr;70(4):480-6
pubmed: 25147086
Int Psychogeriatr. 2012 Jan;24(1):28-37
pubmed: 21843399